Stanley C. Xie

Dec 9, 2024 | journals.plos.org | Stanley C. Xie |Chia-Wei Tai |Craig Morton |Clayton South |PLOS Pathogens

Citation: Xie SC, Tai C-W, Morton CJ, Ma L, Huang S-C, Wittlin S, et al. (2024) A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo. PLoS Pathog 20(12): e1012429. https://doi.org/10.1371/journal.ppat.1012429Editor: Audrey Ragan John, Childrens Hospital of Philadelphia, UNITED STATES OF AMERICAReceived: July 22, 2024; Accepted: October 31, 2024; Published: December 9, 2024Copyright: © 2024 Xie et al.

Oct 17, 2023 | lexology.com | Hannah Cassidy |Matthew Emsley |Simone Hui |Jin Yip Kong |Jeremy Shen |Jason Sung | +2 more

Hong Kong’s Securities and Futures Commission (SFC) has issued a consultation paper proposing draft new guidelines on market soundings. The new guidelines are aimed at clarifying regulatory expectations during market soundings and deterring substandard conduct which could impact the integrity of the market.

Mar 3, 2023 | lexology.com | Matthew Emsley |Jin Yip Kong |Jeremy Shen |Jason Sung |Tommy Tong |Stanley C. Xie

From 31 March 2023, new regulations will come into effect in the People’s Republic of China which will replace the existing PRC regulations governing overseas listings and overseas offerings and the listing of shares by joint stock companies. As a result, the Hong Kong Stock Exchange has issued a consultation paper on consequential updates to the Listing Rules to bring the provisions relating to PRC issuers in line with the new PRC regulations.